http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I726009-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28b2da43a510653090a80aae58d2462c |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2016-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32cdb9c98fb45bcb3c18626dbed00b5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4e043e982d86798cadf0cc9701d1d78 |
publicationDate | 2021-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-I726009-B |
titleOfInvention | Method for analysing cell free neucleosimes of tumor origin from a biological sample by affinity purification, isolating purified tumor dna from a biological sample, detecting an epigenetic epitope of tumor derived nucleosomes in a biological sample, or detecting cancer in an animal or a human subject, or an use of a kit comprising a histone h1 binding agent |
abstract | The present invention relates to the use of a histone H1 binding agent for detecting, isolating and/or purifying cell free nucleosomes of tumor origin from a biological sample. The invention also describes methods of negative or positive selection using nhistone H1 binding agents, in order to enrich a sample for cell free nucleosomes of tumor origin. |
priorityDate | 2016-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 341.